Adenosine analog NITD008 is a potent inhibitor of zika virus

Yong Qiang Deng; Na Na Zhang; Chun Feng Li; Min Tian; Jia Nan Hao; Xu Ping Xie; Pei Yong Shi; Cheng Feng Qin

doi:10.1093/ofid/ofw175

Adenosine analog NITD008 is a potent inhibitor of zika virus

Yong Qiang Deng, Na Na Zhang, Chun Feng Li, Min Tian, Jia Nan Hao, Xu Ping Xie, Pei Yong Shi, Cheng Feng Qin

Biochemistry & Molecular Biology

Research output: Contribution to journal › Article › peer-review

115 Scopus citations

Abstract

The ongoing Zika virus (ZIKV) outbreaks have raised global concerns due to its unexpected clinical manifestations. Antiviral development is of high priority in response to the ZIKV emergency. In this study, we report that an adenosine analog NITD008 has potent in vitro and in vivo antiviral activity against ZIKV. The compound can effectively inhibit the historical and contemporary ZIKV strains in cultures as well as significantly reduce viremia and prevent mortality in A129 mice. Our results have demonstrated that NITD008 is potent inhibitor of ZIKV and can be used as reference inhibitor for future ZIKV antiviral drug screen and discovery.

Original language	English (US)
Journal	Open Forum Infectious Diseases
Volume	3
Issue number	4
DOIs	https://doi.org/10.1093/ofid/ofw175
State	Published - Oct 1 2016

Keywords

Adenosine analog
Antiviral
Mouse model
Zika virus

ASJC Scopus subject areas

Oncology
Clinical Neurology

Access to Document

10.1093/ofid/ofw175

Cite this

@article{1a23cc0fd8eb45f78a653f2bde9b9080,

title = "Adenosine analog NITD008 is a potent inhibitor of zika virus",

abstract = "The ongoing Zika virus (ZIKV) outbreaks have raised global concerns due to its unexpected clinical manifestations. Antiviral development is of high priority in response to the ZIKV emergency. In this study, we report that an adenosine analog NITD008 has potent in vitro and in vivo antiviral activity against ZIKV. The compound can effectively inhibit the historical and contemporary ZIKV strains in cultures as well as significantly reduce viremia and prevent mortality in A129 mice. Our results have demonstrated that NITD008 is potent inhibitor of ZIKV and can be used as reference inhibitor for future ZIKV antiviral drug screen and discovery.",

keywords = "Adenosine analog, Antiviral, Mouse model, Zika virus",

author = "Deng, {Yong Qiang} and Zhang, {Na Na} and Li, {Chun Feng} and Min Tian and Hao, {Jia Nan} and Xie, {Xu Ping} and Shi, {Pei Yong} and Qin, {Cheng Feng}",

note = "Publisher Copyright: {\textcopyright} The Author 2016.",

year = "2016",

month = oct,

day = "1",

doi = "10.1093/ofid/ofw175",

language = "English (US)",

volume = "3",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Adenosine analog NITD008 is a potent inhibitor of zika virus

AU - Deng, Yong Qiang

AU - Zhang, Na Na

AU - Li, Chun Feng

AU - Tian, Min

AU - Hao, Jia Nan

AU - Xie, Xu Ping

AU - Shi, Pei Yong

AU - Qin, Cheng Feng

N1 - Publisher Copyright: © The Author 2016.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The ongoing Zika virus (ZIKV) outbreaks have raised global concerns due to its unexpected clinical manifestations. Antiviral development is of high priority in response to the ZIKV emergency. In this study, we report that an adenosine analog NITD008 has potent in vitro and in vivo antiviral activity against ZIKV. The compound can effectively inhibit the historical and contemporary ZIKV strains in cultures as well as significantly reduce viremia and prevent mortality in A129 mice. Our results have demonstrated that NITD008 is potent inhibitor of ZIKV and can be used as reference inhibitor for future ZIKV antiviral drug screen and discovery.

AB - The ongoing Zika virus (ZIKV) outbreaks have raised global concerns due to its unexpected clinical manifestations. Antiviral development is of high priority in response to the ZIKV emergency. In this study, we report that an adenosine analog NITD008 has potent in vitro and in vivo antiviral activity against ZIKV. The compound can effectively inhibit the historical and contemporary ZIKV strains in cultures as well as significantly reduce viremia and prevent mortality in A129 mice. Our results have demonstrated that NITD008 is potent inhibitor of ZIKV and can be used as reference inhibitor for future ZIKV antiviral drug screen and discovery.

KW - Adenosine analog

KW - Antiviral

KW - Mouse model

KW - Zika virus

UR - http://www.scopus.com/inward/record.url?scp=84996504031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996504031&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofw175

DO - 10.1093/ofid/ofw175

M3 - Article

C2 - 27747251

AN - SCOPUS:84996504031

SN - 2328-8957

VL - 3

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

IS - 4

ER -

Adenosine analog NITD008 is a potent inhibitor of zika virus

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this